Human mast cell tryptase: A stimulus of microvascular leakage and mast cell activation

European Journal of Pharmacology

Volumn 328, Issue 1, 1997, Pages 89-97

  He, Shaoheng ^a   Walls, Andrew F ^a  

^a Immunopharmacology Group   (United Kingdom)

Author keywords

Heparin; Histamine; Histamine receptor antagonist; Mast cell; Microvascular leakage; Proteinase inhibitor; Tryptase

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIMYCIN A1; CIMETIDINE; DEOXYGLUCOSE; MEPYRAMINE; TRYPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; GUINEA PIG; HISTAMINE RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ALVEOLUS CELL; MAST CELL; NONHUMAN; PRIORITY JOURNAL; SKIN;

EID: 0030940777     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83033-6     Document Type: Article

References (55)

1. Ahmed T., Syriste T., Lucio J., Abraham W., Robinson M., D'brot J. Inhibition of antigen-induced airway and cutaneous responses by heparin: a pharmacodynamic study. J. Appl. Physiol. 74:1993;1492-1498.
2. Alter S.C., Schwartz L.B. Effect of histamine and divalent cations on the activity and stability of tryptase from human mast cells. Biochim. Biophys. Acta. 991:1989;426-430.
3. Benyon R.C., Lowman M.A., Church M.K. Human skin mast cells: their dispersion, purification and secretory characterization. J. Immunol. 138:1987;861-867.
4. Bradding, P., Walls, A.F., Church, M.K., 1995. Mast cells and basophils: their role in initiating and maintaining inflammatory responses. In: Holgate, S.T. (Ed.), Immunopharmacology of the Respiratory System. Academic Press, New York, NY, pp. 53-84.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Cairns J.A., Walls A.F. Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J. Immunol. 156:1996;275-283.
7. Christiansen S.C., Proud D., Sarnoff R.B., Cochrane C.G., Juergens U., Zuraw B.L. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects following endobronchial allergen challenge. Am. Rev. Respir. Dis. 145:1992;900-905.
8. Church M.K., Pao G.J.-K., Holgate S.T. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J. Immunol. 129:1982;2116-2121.
9. Clark J.M., Abraham W.M., Fishman C.E., Forteza A., Ahmed A., Cortes A., Warne R.L., Moore W.R., Tanaka R.D. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am. J. Respir. Crit. Care Med. 152:1995;2076-2083.
10. Glenner G.G., Cohen L.A. Histochemical demonstration of a species specific trypsin-like enzyme in mast cells. Nature. 185:1960;846-847.
11. Goldstein S.M., Leong J., Schwartz L.B., Cooke D. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J. Immunol. 148:1992;2475-2482.
12. Hochstrasser G.R.K. Tryptase in nasal fluid is a useful marker of allergic rhinitis. Allergy. 48:1993;72-74.
13. Kalenderian R., Raju L., Roth W., Schwartz L.B., Gruber B., Janoff A. Elevated histamine and tryptase levels in smokers' bronchoalveolar lavage fluid. Chest. 1:1988;119-123.
14. Kato Y., Kido H., Fukusen N., Katunuma N. Peptide boronic acids, substrate analogs, inhibit chymase, and histamine release from rat mast cells. J. Biochem. 103:1988;820-822.
15. Kido H., Fukusen N., Katunuma N. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions. Arch. Biochem. Biophys. 239:1985;436-443.
16. Kido H., Fukusen N., Katunuma N. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release. Biol. Chem. Hoppe-Seyler. 369:1988;95-100.
17. Kimura I., Moritani Y., Tanizaki Y. Basophils in bronchial asthma with reference to reagin-type allergy. Clin. Allergy. 3:1973;195-202.
18. Maier M., Spragg J., Schwartz L.B. Inactivation of human high molecular weight kininogen by human mast cell tryptase. J. Immunol. 130:1983;2353-2356.
19. McEuen A.R., He S., Brander M.L., Walls A.F. Guinea pig lung tryptase: localisation to mast cells and characterisation of the partially purified enzyme. Biochem. Pharmacol. 52:1996;331-340.
20. Meier H.L., Gross C.L., Papirmeister B., Kagey-Sobotka A., Kilduff J.E. Histamine release by esterase inhibitors. Int. Arch. Allergy Appl. Immun. 77:1985;218-221.
21. Naclerio R.M., Proud D., Togias A.G., Adkinson N.F., Meyers D.A., Kagey-Sobotka A., Plaut M., Norman S., Lichtenstein L.M. Inflammatory mediators in late antigen-induced rhinitis. New Engl. J. Med. 313:1985;65-70.
22. Nakajima K., Powers J.C., Ashe B.M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. J. Biol. Chem. 254:1979;4027-4034.
23. Nials A.T., Vardey C.J., Skidmore I.F. The release of histamine from rat mast cells by chymotrypsin. Int. Arch. Allergy Appl. Immun. 70:1983;83-87.
24. Nolte H., Schiotz P.O., Skov P.S. A new glass fibre based histamine analysis for allergy testing in children: results compared with conventional leukocyte histamine release assay, skin prick test, bronchial provocation test, and RAST. Allergy. 42:1987;366-377.
25. Nolte H., Skov P.S., Kruse A., Schiotz P.O. Histamine release from dispersed human intestinal mast cells: a method using biopsies from children and adults. Allergy. 44:1989;543-553.
26. 2 release from mast cells of human lung, tonsil and skin. Allergy. 49:1994;246.
27. 2-receptors in cutaneous inflammation in the guinea-pig produced by histamine and mast cell degranulation. Br. J. Pharmacol. 69:1980;615-623.
28. Proud D., Macglashan D.W., Newball H.H., Schulman E.S., Lichtenstein L.M. Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am. Rev. Respir. Dis. 132:1985;405-408.
29. Proud D., Seikierski E.S., Bailey G.S. Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity. Biochem. Pharmacol. 37:1988;1473-1480.
30. Razin E., Marx G. Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J. Immunol. 133:1984;3282-3285.
31. Rubin R.M., Noland J., Rosenbaum J.T. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants. Circ. Shock. 36:1992;217-227.
32. Rubinstein I., Nadel J.A., Graf P.D., Caughey G.H. Mast cell chymase potentiates histamine-induced weal formation in the skin of ragweed-allergic dogs. J. Clin. Invest. 86:1990;555-559.
33. Ruoss S.J., Hartmann T., Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88:1991;493-499.
34. Schechter N.M., Grace Y.E., Darrell R.M. Human skin tryptase: kinetic characterization of its spontaneous inactivation. Biochemistry. 32:1993;2617-2625.
35. Schick B. Cleavage of a rat serosal mast cell membrane component during degranulation mediated by chymase, a secretory granule protease. Immunology. 69:1990;423-428.
36. Schwartz, L.B., 1990. Tryptase from human mast cells: biochemistry, biology and clinical utility. In: Schwartz, L.B. (Ed.), Neutral Proteases of Mast Cells. Monogr. Allergy. Karger, Basel, pp. 90-113.
37. Schwartz L.B., Bradford T.R. Regulation of tryptase from human lung mast cells by heparin. J. Biol. Chem. 261:1986;7372-7379.
38. Schwartz L.B., Lewis R.A., Austen K.F. Tryptase from human pulmonary mast cells. Purification and characterisation. J. Biol. Chem. 256:1981;11939-11943.
39. Schwartz L.B., Maier M., Spragg J. Interaction of low molecular weight kininogen with human mast cell tryptase. Adv. Exp. Med. Biol. 198A:1986;105-111.
40. Schwartz L.B., Irani A.A., Roller K., Castells M.C., Schechter N.M. Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J. Immunol. 138:1987;2611-2615.
41. Schwartz L.B., Atkins P.C., Bradford T.R., Fleekop P., Shalit M., Zweiman B. Release of tryptase together with histamine during immediate cutaneous response to allergen. J. Allergy Clin. Immunol. 80:1987;850-855.
42. Schwartz L.B., Metcalfe D.D., Miller J.S., Earl H., Sullivan T. Tryptase levels as an indicator mast cell activation in systemic anaphylaxis and mastocytosis. New Engl. J. Med. 316:1987;1622-1626.
43. Sekizawa K., Caughey G.H., Lazarus S.C., Gold W.M., Nadel J.A. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J. Clin. Invest. 83:1989;175-179.
44. Smith J.K., Hougland M.W., Johnson D.A. Human lung tryptase. Purification and characterisation. J. Biol. Chem. 259:1984;11046-11051.
45. Spector W.G., Willoughby D.A. The suppression by anti-esterases of increased capillary permeability in acute inflammation. J. Path. Bact. 79:1960;21-35.
46. Stewart G.A., Boyd S.M., Bird C.H., Krska K.D., Kollinger M.R., Thompson P.J. Immunobiology of the serine protease allergens from house dust mites. Am. J. Ind. Med. 25:1994;105-107.
47. Tam E.K., Caughey G.H. Degradation of airway neuropeptides by human lung tryptase. Am. Rev. Respir. Cell. Mol. Biol. 3:1990;27-32.
48. Walls, A.F., 1995. The roles of neutral proteases in asthma and rhinitis. In: Busse, W.W., Holgate, S.T. (Eds.), Asthma and Rhinitis. Blackwell, Oxford, pp. 801-824.
49. Walls A.F., Suckling A.J., Rumsby M.G. IgG subclass responses and immediate skin sensitivity in guinea-pigs with chronic relapsing experimental allergic encephalomyelitis. Int. Arch. Allergy Appl. Immunol. 84:1987;109-115.
50. Walls A.F., Jones D.B., William J.H., Church M.K., Holgate S.T. Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J. Pathol. 162:1990;119-126.
51. Walls A.F., Bennett A.R., Mcbride H.M., Glennie M.J., Holgate S.T., Church M.K. Production and characterization of monoclonal antibodies specific for human mast cell tryptase. Clin. Exp. Allergy. 20:1990;581-589.
52. Walls A.F., Bennett A.R., Godfrey R.C., Holgate S.T., Church M.K. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. Clin. Sci. 81:1991;183-188.
53. Walls A.F., Brain S.D., Desai A., Jose P.J., Hawkings E., Church M.K., Williams T.J. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem. Pharmacol. 43:1992;1243-1248.
54. Walls A.F., Bennett A.R., Suieras-Dias J., Olsson H. The kininogenase activity of human mast cell tryptase. Biochem. Soc. Trans. 20:1992;260S.
55. Wenzel S.E., Fowler A.A., Schwartz L.B. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with or without asthma. Am. Rev. Respir. Dis. 137:1988;1002-1008.